openPR Logo
Press release

Low Molecular Weight Heparin Market at a CAGR of 8.4% during the forecast 2021-2032 | Aspen Holdings, Changzhou Qianhong Bio-pharma, LEOPHARMA A/S

04-03-2023 03:41 AM CET | Health & Medicine

Press release from: Global Insight Services

Low Molecular Weight Heparin Market

Low Molecular Weight Heparin Market

The global Low Molecular Weight Heparin Market was valued at 3.8 billion in 2022 and it is anticipated to grow up to USD 8.5 billion by 2032, at a CAGR of 8.4% during the forecast period.

Low molecular weight heparin (LMWH) is a class of anticoagulants. They are used to treat venous thromboembolism (deep vein thrombosis and pulmonary embolism) and myocardial infarction, and prevent blood clots. Low molecular weight heparin offers more advantages than heparin as it has better bioavailability, longer half-life, simplified dosing, predictable anticoagulant response, lower HIT risk, and lower osteoporosis risk.

To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS10497

 LMWH can be administered subcutaneously once or twice daily without coagulation monitoring, even when the drug is administered in treatment doses. Most patients do not require coagulation monitoring with LMWH.
The effects of unfractionated heparin (UFH) or standard heparin vary from patient to patient. Therefore, it can only be administered to hospitalized patients under supervision. In addition, the LMWH has more predictable pharmacokinetic properties than unfractionated heparin, which allows its administration in fixed doses based on laboratory monitoring, without the need for dose adjustments.

Market Trends and Drivers

Developments by Companies to Drive Low Molecular Weight Heparin Market:

The Shenzhen Panorama Network has increased the production of new LMWH products to expand its presence in the market. In May 2020, Meitheal Pharmaceuticals Inc. received an FDA approval for Enoxaparin Sodium Injection (USP), a generic equivalent of Lovenox. The increasing propensity of research institutes to encourage the use of LMWH in new treatments would boost its demand in the future. The LMWH helps improve coagulation disorder occurring in COVID-19 patients; it exerts anti-inflammatory effects by reducing IL-6 and stimulating lymphocyte percentage. This application of LMWH is paving the way for well-controlled clinical trials in the field of COVID-19.

 The American University of Beirut Medical Center is sponsoring a study of bemiparin sodium (a form of LMWH), which is in Phase IV clinical trials that are being conducted for its ability to improve pregnancy outcomes in patients with recurrent implantation failure, who are undergoing IVF/ICSI treatment. In addition, important players in the market are working with hospitals to strengthen their product portfolio. For example, Bayer is working with Assistance Publique - Hopitaux de Paris to investigate the combination of rivaroxaban and low molecular weight heparin against neoplasms and venous thromboembolism, which is in the Phase 3 trial.

View Detailed Report Description - https://www.globalinsightservices.com/reports/low-molecular-weight-heparin-market/

Major Players in the Global Low Molecular Weight Heparin Market

Market players are focusing on strategic collaborations to enhance their product offerings. Some prominent participants in the global Low Molecular Weight Heparin market include Aspen Holdings, Changzhou Qianhong Bio-pharma, LEOPHARMA A/S, Teva Pharmaceutical Industries Ltd., B. Braun Medical Inc., Pfizer Inc., Sanofi-Aventis, Dr. Reddy's Laboratories Limited, and Abbott among others.

COVID-19 Impact

The spread of the COVID-19 pandemic has emphasized health data sharing and interoperability under the microscope. The infection of novel coronavirus in children is mild compared to adults, and children are assigned a better prognosis. The interruptions in the supply chain and the massive demand for efficient treatments for COVID-19 have put the health research industry in Asia-Pacific in a crucial position.

Get Customized Report as Per Your Requirement - https://www.globalinsightservices.com/request-customization/GIS10497

Global Low Molecular Weight Heparin Market Segmentation

By Drug Type

Enoxaparin
Dalteparin
Nadroparin
Bemiparin
Tinzaparin
Others

By Packaging

Multi-vials
Prefilled Syringes

By Application
Deep Vein Thrombosis
Acute Coronary Syndrome (ACS)
Pulmonary Embolism
Atrial Fibrillation

By End-user

Hospitals
Clinics
Ambulatory Surgical Centers

Buy Now - https://www.globalinsightservices.com/checkout/single_user/GIS10497

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Low Molecular Weight Heparin Market at a CAGR of 8.4% during the forecast 2021-2032 | Aspen Holdings, Changzhou Qianhong Bio-pharma, LEOPHARMA A/S here

News-ID: 2997119 • Views:

More Releases from Global Insight Services

Governance Risk and Compliance (GRC) Platform Market to Expand From $53.5 Billion in 2024 to $152 Billion by 2034 With 11% CAGR
Governance Risk and Compliance (GRC) Platform Market to Expand From $53.5 Billio …
The Governance Risk And Compliance (GRC) Platform Market has emerged as a cornerstone for organizations striving to enhance accountability, streamline risk management, and meet growing regulatory demands. GRC platforms provide an integrated framework that enables companies to monitor compliance, manage risks, and ensure governance practices are aligned with industry standards. By combining risk assessment, audit management, compliance tracking, and policy enforcement, these platforms empower businesses to strengthen decision-making and safeguard
Electronic Manufacturing Services (EMS) Market to Expand From $504.22 Billion in 2024 to $1,072.15 Billion by 2034 With 7.8% CAGR
Electronic Manufacturing Services (EMS) Market to Expand From $504.22 Billion in …
The Electronic Manufacturing Services (EMS) Market has become one of the most crucial sectors in the global technology-driven economy. EMS refers to the outsourcing of design, production, testing, and distribution of electronic components for original equipment manufacturers (OEMs). These services are indispensable across industries such as consumer electronics, automotive, telecommunications, and healthcare. In 2024, the EMS sector continues to play a pivotal role in improving efficiency, lowering production costs, and
Catamaran Market Is Anticipated To Expand From $4.2 Billion In 2024 To $7.8 Billion By 2034
Catamaran Market Is Anticipated To Expand From $4.2 Billion In 2024 To $7.8 Bill …
Market Overview The Catamaran Market is witnessing remarkable expansion, driven by the growing demand for recreational boating, marine tourism, and eco-friendly vessel options. Catamarans, recognized for their stability, spaciousness, and fuel efficiency, are increasingly preferred for leisure sailing, luxury tourism, and competitive racing. The market includes a wide range of offerings such as sailing catamarans, power catamarans, luxury yachts, and charter vessels, each catering to unique consumer preferences. Innovations in sustainable
Gear Motor Market to Expand From $24.5 Billion in 2024 to $39.8 Billion by 2034 With 5% CAGR
Gear Motor Market to Expand From $24.5 Billion in 2024 to $39.8 Billion by 2034 …
The gear motor market is witnessing steady growth as industries worldwide increasingly depend on reliable and energy-efficient motion control systems. Gear motors, which combine a motor with a gearbox, play a vital role in converting electrical energy into mechanical torque with higher efficiency. These systems are essential across sectors like automotive, robotics, manufacturing, and renewable energy, offering enhanced precision, power transmission, and performance. The market is strongly supported by the

All 5 Releases


More Releases for Molecular

Molecular Breeding Market Report 2024 - Molecular Breeding Market Size, Share An …
"The Business Research Company recently released a comprehensive report on the Global Molecular Breeding Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The molecular breeding market size
Molecular Quality Controls: Ensuring Precision and Reliability in Molecular Diag …
Introduction Molecular quality controls (MQCs) play a critical role in molecular diagnostics, helping laboratories and healthcare providers ensure the accuracy, reliability, and consistency of diagnostic tests. These quality controls are essential in detecting and monitoring infectious diseases, genetic disorders, cancer biomarkers, and other molecular targets. By providing standards that verify the performance of diagnostic assays, MQCs help reduce errors, minimize false results, and maintain compliance with regulatory standards. As the demand
Molecular Diagnostic Platform Market Advancing Molecular Diagnostics with Innova …
Global Molecular Diagnostic Platform Market Overview: The Molecular Diagnostic Platform market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others. In recent years, the Molecular Diagnostic Platform market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth
Molecular Modeling Market - Visualizing the unseen: Molecular modeling for grou …
Newark, New Castle, USA: The "Molecular Modeling Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Molecular Modeling Market: https://www.growthplusreports.com/report/molecular-modeling-market/8615 This latest report researches the industry structure, sales, revenue,
Molecular Diagnostics Market - Empowering healthcare through molecular precision …
Newark, New Castle, USA: The "Molecular Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Molecular Diagnostics Market: https://www.growthplusreports.com/report/molecular-diagnostics-market/7674 This latest report researches the industry structure, sales, revenue,
Molecular Imaging Device Market scenario for 2022 | Trivitron Healthcare, Molecu …
The Molecular Imaging Device market report anticipate the market growth and recent developments in market competition which helps players to strategies and analysis the position in Molecular Imaging Device market. It also indicates the risk factors, advancements, market drivers, revenue, business scenario, growth potential, market scope, new trends, and historical data of Molecular Imaging Device market. With this futuristic approach researchers also provides a close study of market forecast, overview